Sperogenix Therapeutics
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
no.275 Ruiping Rd, Xuhui Disrict, Shangh...Phone Number
+86 2154565990Website
www.sperogenix.comRevenue
$18 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Sperogenix Therapeutics
Sperogenix Therapeutics is an innovative company focused on the research and commercialization of drugs for genetic rare diseases in China. It aims to provide clinically accessible products for rare disease patients and offers promising commercial solutions for rare disease treatments. The company is dedicated to empowering the rare disease community by addressing the overall needs of patients, including medication, treatment, rehabilitation, and payment challenges. Additionally, it supports patient organizations in enhancing their capabilities and linking resources for sustainable development.Explore more
Sperogenix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sperogenix Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sperogenix Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check if Sperogenix Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sperogenix Therapeutics launches new products
Earning: See what the market has to say on Sperogenix Therapeutics recently announced quarterly report
Click to see if Sperogenix Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sperogenix Therapeutics is spiking on competitors!
Sperogenix Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sperogenix Therapeutics
Recommended Actions
Reach out to Masked Content who joined Sperogenix Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Sperogenix Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sperogenix Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sperogenix Therapeutics.
Sperogenix Therapeutics Tech Stack
A closer look at the technologies used by Sperogenix Therapeutics
Sperogenix Therapeutics News & Media
Santhera Announces Approval from China’s NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Pratteln, Switzerland, December 11, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that China’s National Medical Products Administration (NMPA) has approved AGAMREE® (vamorolone) for use in China in patients aged 4 years and older.Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
Pratteln, Switzerland, June 10, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its partner Sperogenix Therapeutics has launched a paid-for Early Access Program (EAP) for AGAMREE® (vamorolone) in China for patients with Duchenne muscular dystrophy (DMD).Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA
Pratteln, Switzerland, March 27, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that the China National Medical Products Administration (NMPA) has accepted for priority review the new drug application (NDA) for vamorolone in Duchenne muscular dystrophy (DMD) which was submitted by Sperogenix Therapeutics, Santhera's specialized rare disease partner for China.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sperogenix Therapeutics
Sign Up For FreeTo access detailed company insights
Sperogenix Therapeutics is an innovative company focused on the research and commercialization of drugs for genetic rare diseases in China. It aims to provide clinically accessible products for rare disease patients and offers promising commercial solutions for rare disease treatments. The company is dedicated to empowering the rare disease communi... Read More
